UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases. Read More
Bangalore (Karnataka) [India], May 15 (ANI/PRNewswire): Sonata Software, a global IT services and technology solutions company, today reported its ... ...